Todd Zavodnick
Vorstandsvorsitzender bei Dermavant Sciences Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark Foley | M | 58 | 12 Jahre | |
| Kenneth Ludlum | M | 70 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 5 Jahre |
| Timothy Nelson | M | 60 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 5 Jahre |
| Ambrose Bailey | M | 60 | 7 Jahre | |
| Tobin Schilke | M | 49 | 6 Jahre | |
| Myrtle Potter | F | 65 |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 6 Jahre |
| Yen You Zheng | M | 67 | 5 Jahre | |
| Frank Torti | M | 45 |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 6 Jahre |
| Sigurd Kirk | M | 57 | 7 Jahre | |
| Nancy Beesley | F | - |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 2 Jahre |
| Conor Gallagher | M | - | 6 Jahre | |
| Kira Schwartz | F | - | 7 Jahre | |
| James Joseph Florio | M | 86 |
Rutgers State University of New Jersey
| 30 Jahre |
| Michael Clement | M | 67 |
The University of Texas at Austin
| 20 Jahre |
| Frederick C. Beddingfield | M | 59 |
Children's Skin Disease Foundation
| - |
| Merrick McCracken | M | - |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | 14 Jahre |
| Igor Correia de Almeida | M | 63 |
The University of Texas at Austin
| 20 Jahre |
| John Donofrio | M | 56 |
Children's Skin Disease Foundation
| - |
| Chris Chapman | M | - |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark M. Sieczkarek | M | 69 | 5 Jahre | |
| John J. McGovern | M | - | 2 Jahre | |
| Richard A. Leavy | M | - |
Rutgers State University of New Jersey
| 9 Jahre |
| Dustin Sjuts | M | 45 | 6 Jahre | |
| Cyril Allouche | M | 52 | 2 Jahre | |
| Matthew D. Boyd | M | - |
The University of Texas at Austin
| 5 Jahre |
| Phillip C. Zerrillo | M | 65 |
The University of Texas at Austin
| 5 Jahre |
| Mohammed Hoque | M | 46 |
The University of Texas at Austin
| 5 Jahre |
| Brendan Achariyakosol | M | - |
The University of Texas at Austin
| 11 Jahre |
| Chien Chung Nieh | M | 64 |
Rutgers State University of New Jersey
| 4 Jahre |
| Danika R. Harrison | F | 48 | 3 Jahre | |
| Stuart Raetzman | M | 61 |
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX.
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | - |
| Joel A. Shapiro | M | 53 |
Rutgers State University of New Jersey
| 7 Jahre |
| Joel Marc Kallman | M | - |
Rutgers State University of New Jersey
| - |
| Prem Nainani | M | - |
The University of Texas at Austin
| 6 Jahre |
| Eric Pearson | M | - |
The University of Texas at Austin
| 5 Jahre |
| Natasha Tosirisuk | F | - |
The University of Texas at Austin
| 5 Jahre |
| Kendall Helfenbein | M | - |
The University of Texas at Austin
| 4 Jahre |
| Andrew Schiff | M | 58 | 7 Jahre | |
| Justin Bernard Smith | M | - |
The University of Texas at Austin
| 5 Jahre |
| Caryn McDowell | F | 54 | - | |
| Jim Ciprich | M | - |
Rutgers State University of New Jersey
| 6 Jahre |
| Marvin Kwan | M | - |
The University of Texas at Austin
| 5 Jahre |
| Turab Bajwa | M | - |
The University of Texas at Austin
| 5 Jahre |
| Sam F. Stoutner | M | 37 |
The University of Texas at Austin
| 5 Jahre |
| Steven Hirsch | M | - |
The University of Texas at Austin
| 5 Jahre |
| Rui Mao | M | 49 |
The University of Texas at Austin
| 3 Jahre |
| Christy Cardenas | F | 37 |
The University of Texas at Austin
| 5 Jahre |
| Kyle Hranicky | M | - |
The University of Texas at Austin
| 5 Jahre |
| John Batton | M | - |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | 3 Jahre |
| Megan Light | F | - |
The University of Texas at Austin
| 5 Jahre |
| SHORT REBECCA | F | - |
The University of Texas at Austin
| 4 Jahre |
| Rachel Foley | F | - |
The University of Texas at Austin
| 4 Jahre |
| Hemant Pande | M | - |
Rutgers State University of New Jersey
| 5 Jahre |
| Daniel G. Polhamus | M | - |
The University of Texas at Austin
| 5 Jahre |
| David Endicott | M | 58 | 1 Jahre | |
| Bryan Roberts | M | 57 | 8 Jahre | |
| Lauren Silvernail | F | 65 | 5 Jahre | |
| B. M. Rankin | M | 94 |
The University of Texas at Austin
| 7 Jahre |
| Ronald Eastman | M | 71 | 8 Jahre | |
| D. Grossman | M | 63 | 4 Jahre | |
| Kevin O'Boyle | M | 68 | 6 Jahre | |
| John Moran | M | 48 |
Rutgers State University of New Jersey
| 6 Jahre |
| Keith Sullivan | M | 65 | 5 Jahre | |
| Mary Fisher | F | 62 | 5 Jahre | |
| T. Alex McPherson | M | 85 | 10 Jahre | |
| Alex Greyserman | M | - |
Rutgers State University of New Jersey
| 5 Jahre |
| John Blair Cummings | M | - |
Rutgers State University of New Jersey
| 11 Jahre |
| Leonard Goldberg | M | 61 |
Rutgers State University of New Jersey
| 13 Jahre |
| Zhaobo Wang | M | 67 |
Rutgers State University of New Jersey
| 4 Jahre |
| Sergio Garcia-Rodriguez | M | 62 | 5 Jahre | |
| Michael Ian Mellon | M | - |
The University of Texas at Austin
| 5 Jahre |
| Wesley Gallup | M | - |
The University of Texas at Austin
| 6 Jahre |
| Michael Schemick | M | 50 |
Rutgers State University of New Jersey
| 6 Jahre |
| Ashley Baum | F | - |
The University of Texas at Austin
| 5 Jahre |
| Shari Ledbetter | F | - |
The University of Texas at Austin
| 5 Jahre |
| Vincent Ippolito | M | 65 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 2 Jahre |
| Patrick Williams | M | 51 | 4 Jahre | |
| Massimo Radaelli | M | 65 | 2 Jahre | |
| Ali Merchant | M | - |
The University of Texas at Austin
| 5 Jahre |
| David Sobernheim | M | - |
The University of Texas at Austin
| 3 Jahre |
| Francisco Campos | M | - |
The University of Texas at Austin
| 1 Jahre |
| Amrita Dukeshier | F | - |
The University of Texas at Austin
| 2 Jahre |
| John Y. Chen | M | - |
The University of Texas at Austin
| 4 Jahre |
| Ryan Deschner | M | - |
The University of Texas at Austin
| 4 Jahre |
| Michael Parent | M | - |
The University of Texas at Austin
| 4 Jahre |
| Kevin J. L’abbé | M | 43 |
The University of Texas at Austin
| 4 Jahre |
| Xi Chen | M | - |
The University of Texas at Austin
| 5 Jahre |
| Matthew Hartman | M | - |
The University of Texas at Austin
| 2 Jahre |
| Ankit Dalal | M | - |
The University of Texas at Austin
| 4 Jahre |
| Scotty Reynolds | M | - |
The University of Texas at Austin
| 4 Jahre |
| Tyler Dunn | M | - |
The University of Texas at Austin
| 4 Jahre |
| John Johanning | M | 38 |
The University of Texas at Austin
| 4 Jahre |
| Natalie Brod | F | - |
The University of Texas at Austin
| 4 Jahre |
| Alexander Farquharson | M | 40 |
The University of Texas at Austin
| 4 Jahre |
| Jordan Waldrep | M | - |
The University of Texas at Austin
| 2 Jahre |
| Chris Robertson | M | - |
The University of Texas at Austin
| 4 Jahre |
| Joanne Choi | F | - |
The University of Texas at Austin
| 4 Jahre |
| Jeoffrey Restituto Lambujon | M | - |
The University of Texas at Austin
| 5 Jahre |
| Russell Chad Mollen | M | 41 |
The University of Texas at Austin
| 4 Jahre |
| Said Aziz | M | - |
The University of Texas at Austin
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 99 | 99,00% |
| Vereinigtes Königreich | 5 | 5,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Todd Zavodnick
- Persönliches Netzwerk
